Table 1 Preoperative patients details
From: St. Jude Medical Trifecta aortic valve: results from a prospective regional multicentre registry
| Variablesa | All implants (n = 178) |
|---|---|
| Demographics | |
| Age, yrs | 75.4 ± 7.7 (72-81) |
| Female, n (%) | 83 (46.6) |
| BSA, m2 | 1.60 ± 0.33 (1.38-1.79) |
| Cardiac presentation | |
| Previous AMI, n (%) | 22 (12.4) |
| CAD, n (%) | 68 (38.2) |
| History of AF, n (%) | 25 (14.0) |
| Preoperative NYHA, n (%) | |
| Class I | 13 (7.3) |
| Class II | 72 (40.4) |
| Class III | 78 (43.8) |
| Class IV | 15 (8.4) |
| Comorbidities | |
| Hypertension, n (%) | 136 (76.4) |
| Diabetes, n (%) | 49 (27.5) |
| COPD, n (%) | 24 (13.5) |
| PVD, n (%) | 52 (29.2) |
| Dyslipidemia, n (%) | 83 (46.6) |
| Renal dysfunction, n (%) | 13 (7.3) |
| Renal failure-dialysis, n (%) | 7 (3.9) |
| Logistic EuroSCORE, % | 7.7 ± 6.7 (3.0-11.0) |
| Etiology | |
| Calcified, n (%) | 120 (67.4) |
| Rheumatic, n (%) | 11 (6.2) |
| Degenerative, n (%) | 35 (19.7) |
| Annular dilatation, n (%) | 5 (2.8) |
| Endocarditis, n (%) | 7 (3.9) |